Results 131 to 140 of about 11,724,943 (303)
This study shows that copy number variations (CNVs) can be reliably detected in formalin‐fixed paraffin‐embedded (FFPE) solid cancer samples using ultra‐low‐pass whole‐genome sequencing, provided that key (pre)‐analytical parameters are optimized.
Hanne Goris +10 more
wiley +1 more source
Computer-Assisted Performance-Based Assessment for Mental Health: A Scoping Review. [PDF]
Li H, Li S.
europepmc +1 more source
Methods to improve antibody–drug conjugate (ADC) treatment durability in cancer therapy are needed. We utilized ADCs and immune‐stimulating antibody conjugates (ISACs), which are made from two non‐competitive antibodies, to enhance the entry of toxic payloads into cancer cells and deliver immunostimulatory agents into immune cells.
Tiexin Wang +3 more
wiley +1 more source
Reducing Health Inequities in Australia: The Role of Place-Based Action and Spatial Data Infrastructure. [PDF]
Olsen JR +3 more
europepmc +1 more source
Ada Colau i la Plataforma Afectats per la Hipoteca. Entrevista
Observatori Conflicte Social
doaj
Etoposide induces DNA damage, activating p53‐dependent apoptosis via caspase‐3/7, which cleaves PARP1. Dammarenediol II enhances this apoptotic pathway by suppressing O‐GlcNAc transferase activity, further decreasing O‐GlcNAcylation. The reduction in O‐GlcNAc levels boosts p53‐driven apoptosis and influences the Akt/GSK3β/mTOR signaling pathway ...
Jaehoon Lee +8 more
wiley +1 more source
"<i>With all your friends in your pocket</i>" - a qualitative study about adolescents' experiences with social media from a health-promoting perspective. [PDF]
Ytrearne TV +4 more
europepmc +1 more source
Stéphane Rozes y la movilización social en Francia. Entrevista
Observatori Conflicte Social
doaj
N. Ellison, C. Steinfield, Cliff Lampe
semanticscholar +1 more source
Aptamers are used both therapeutically and as targeting agents in cancer treatment. We developed an aptamer‐targeted PLGA–TRAIL nanosystem that exhibited superior therapeutic efficacy in NOD/SCID breast cancer models. This nanosystem represents a novel biotechnological drug candidate for suppressing resistance development in breast cancer.
Gulen Melike Demirbolat +8 more
wiley +1 more source

